Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gen Takayanagi"'
Autor:
Linong Ji, Jianhua Ma, Weiping Lu, Jingdong Liu, Jiao’e Zeng, Jialin Yang, Wei Li, Xiuzhen Zhang, Xinhua Xiao, Gen Takayanagi, Yi Wang
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 537-545 (2021)
Abstract Aims/Introduction Although the efficacy of teneligliptin, a highly selective dipeptidyl peptidase‐4 inhibitor, has been amply studied for the treatment of type 2 diabetes, no clinical trials of teneligliptin have been carried out in China.
Externí odkaz:
https://doaj.org/article/60660e466b1a4af9ac2013402767b383
Autor:
Linong Ji, Ling Li, Jianhua Ma, Xuefeng Li, Dongmei Li, Bangzhu Meng, Weiping Lu, Jiao Sun, Yanmei Liu, Gen Takayanagi, Yi Wang
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Abstract Introduction We evaluated the efficacy and safety of teneligliptin compared with placebo when added to metformin therapy in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy. Methods This multicentre, r
Externí odkaz:
https://doaj.org/article/a2759437d7f24e03b6cd9180d3939d04
Autor:
Jingdong Liu, Jiao'e Zeng, Xinhua Xiao, Linong Ji, Xiuzhen Zhang, Wei Li, Weiping Lu, Jianhua Ma, Jialin Yang, Yi Wang, Gen Takayanagi
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 537-545 (2021)
Journal of Diabetes Investigation, Vol 12, Iss 4, Pp 537-545 (2021)
Aims/Introduction Although the efficacy of teneligliptin, a highly selective dipeptidyl peptidase‐4 inhibitor, has been amply studied for the treatment of type 2 diabetes, no clinical trials of teneligliptin have been carried out in China. We evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae74e6358411a67b0a8102d2421cf44
https://doi.org/10.1111/jdi.13389
https://doi.org/10.1111/jdi.13389
Autor:
Weiping Lu, Jianhua Ma, Dongmei Li, Jiao Sun, Xuefeng Li, Bangzhu Meng, Yanmei Liu, Ling Li, Gen Takayanagi, Yi Wang, Linong Ji
Publikováno v:
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Introduction We evaluated the efficacy and safety of teneligliptin compared with placebo when added to metformin therapy in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy. Methods This multicentre, randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d611ec774613f731f2f0fa69fee0ef
https://doi.org/10.1002/edm2.222
https://doi.org/10.1002/edm2.222
Autor:
Kazutoshi Murotomi, Norio Takagi, Gen Takayanagi, Kouichi Tanonaka, Megumi Ono, Satoshi Takeo
Publikováno v:
Journal of Neurochemistry. 105:1625-1634
The contribution of metabotropic glutamate receptors to brain injury after in vivo cerebral ischemia remains to be determined. We investigated the effects of the metabotropic glutamate receptor 1 (mGluR1) antagonist LY367385 on brain injury after tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93be3cde22f216007819b7e5983d676a
https://doi.org/10.1111/j.1471-4159.2008.05260.x
https://doi.org/10.1111/j.1471-4159.2008.05260.x